Corpus 1,273 assessed · 1,174 scored · 643 reproduced ≥75 · 169 flagged ·∅ 74.1/100

Publications 3 Datasets 392.5k Experiments 4.7k

Explore

Filters: US ✕ 1 ✕ rna-sequencing ✕ clear all

3 matching publication(s)

Publication	Journal	Year	Score	Verdict
FOXM1 inhibitor, RCM‑1, enhances venetoclax mediated apoptosis through downregulation of ATP2B4 in rhabdomyosarcoma. ⚑ PMID 41789627	Int J Oncol	2026	10	10/100 ⚑
Molecular and Clinical Relevance of ZBTB38 Expression Levels in Prostate Cancer. ⚑ PMID 32365491	Cancers (Basel)	2020	35	L1 35/100 ⚑
PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment. PMID 31881074	PLoS Pathog	2019	85	L1 85/100

FOXM1 inhibitor, RCM‑1, enhances venetoclax mediated apoptosis through downregulation of ATP2B4 in rhabdomyosarcoma.⚑

PMID 41789627 · Int J Oncol · 2026

10/100 ⚑

Molecular and Clinical Relevance of ZBTB38 Expression Levels in Prostate Cancer.⚑

PMID 32365491 · Cancers (Basel) · 2020

L1 35/100 ⚑

PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment.

PMID 31881074 · PLoS Pathog · 2019

L1 85/100